Irritable Bowel Syndrome Ibs Type D clinical trials

Explore recruiting irritable bowel syndrome ibs type d clinical trials.

Recruiting irritable bowel syndrome ibs type d studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Irritable Bowel Syndrome Ibs Type D trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Pilot / Phase 2 Clinical Trial of GSL-01-001 Administered Orally for 12 Weeks Preceded by a 2 Week Screening Period in Patients Presenting with Symptoms Associated with Irritable Bowel Syndrome with code GSL-01-001

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Irritable Bowel Syndrome Ibs Type D trials by city

Irritable Bowel Syndrome Ibs Type D in Toronto Irritable Bowel Syndrome Ibs Type D in Vancouver Irritable Bowel Syndrome Ibs Type D in Montreal Irritable Bowel Syndrome Ibs Type D in Calgary Irritable Bowel Syndrome Ibs Type D in Edmonton Irritable Bowel Syndrome Ibs Type D in Ottawa Irritable Bowel Syndrome Ibs Type D in Winnipeg Irritable Bowel Syndrome Ibs Type D in Quebec City Irritable Bowel Syndrome Ibs Type D in Hamilton Irritable Bowel Syndrome Ibs Type D in Kitchener Irritable Bowel Syndrome Ibs Type D in London Irritable Bowel Syndrome Ibs Type D in Halifax Irritable Bowel Syndrome Ibs Type D in New York Irritable Bowel Syndrome Ibs Type D in Los Angeles Irritable Bowel Syndrome Ibs Type D in Chicago Irritable Bowel Syndrome Ibs Type D in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease